Pharmacy & Drug Pricing
Expert articles and analysis related to pharmacy & drug pricing.
AI Summary — Last 24 Hours
Drug pricing pressure is converging on care delivery: high out-of-pocket costs are adding administrative workload for physicians as they search for affordable therapies, while GLP-1 coverage decisions remain driven more by price than clinical evidence—creating adherence, access, and total-cost-of-care challenges for ACOs, Medicare Advantage plans, and employers managing cardiometabolic risk. At the same time, 340B scrutiny is intensifying as hospitals work to preserve discount eligibility amid Medicaid-related pressures and critics cite lower charity-care spending at some 340B hospitals, raising stakes for safety-net financing, pharmacy contracting, and population health budgets (340B eligibility pressure; physician burden from drug costs).
Related Articles
Hospitals are scrambling to keep 340B discounts. Here’s what to know
Hospitals are scrambling to keep 340B discounts. Here’s what to know  Modern Healthcare News
Millions of Americans could lose access to cheap Canadian prescriptions next month: 3 notes
Millions of Americans could lose access to cheap Canadian prescriptions next month: 3 notes  Becker's Hospital Review
Opposing Sides of 340B Debate Converge on Data Clearinghouse, Patient Definition
340B hospitals lag behind peers in charity care spending: report
The findings add new fodder for critics who say 340B has ballooned out of control with no corresponding benefit to patients. One hospital group called the report “another in a long line of misleading ...
AHA seeks permanent 340B rebate ban: 6 things to know
AHA seeks permanent 340B rebate ban: 6 things to know  Becker's Hospital Review
Hospitals are scrambling to keep 340B discounts. Here’s what to know
Hospitals are scrambling to keep 340B discounts. Here’s what to know  Modern Healthcare News
Report: High Drug Costs Are Creating Hidden Burden for Physicians
When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 Physician Drug Cost Survey by RazorMetrics examined how prescription cost pr...